Omnicell Accounts Payable vs Total Current Liabilities Analysis
OMCL Stock | USD 27.46 0.45 1.61% |
Omnicell financial indicator trend analysis is much more than just breaking down Omnicell prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Omnicell is a good investment. Please check the relationship between Omnicell Accounts Payable and its Total Current Liabilities accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.
Accounts Payable vs Total Current Liabilities
Accounts Payable vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Omnicell Accounts Payable account and Total Current Liabilities. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Omnicell's Accounts Payable and Total Current Liabilities is 0.83. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Omnicell, assuming nothing else is changed. The correlation between historical values of Omnicell's Accounts Payable and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Omnicell are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Accounts Payable i.e., Omnicell's Accounts Payable and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.83 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Accounts Payable
An accounting item on the balance sheet that represents Omnicell obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Omnicell are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Total Current Liabilities
Total Current Liabilities is an item on Omnicell balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Omnicell are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Omnicell's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Omnicell current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.At this time, Omnicell's Selling General Administrative is quite stable compared to the past year. Enterprise Value Over EBITDA is expected to rise to 34.21 this year, although the value of Tax Provision will most likely fall to (2.8 M).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 554.7M | 589.0M | 496.8M | 521.7M | Total Revenue | 1.1B | 1.3B | 1.1B | 1.2B |
Omnicell fundamental ratios Correlations
Click cells to compare fundamentals
Omnicell Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Omnicell fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.2B | 1.8B | 2.1B | 2.2B | 2.2B | 2.3B | |
Short Long Term Debt Total | 100.7M | 516.1M | 528.1M | 616.7M | 614.1M | 644.8M | |
Other Current Liab | 89.7M | 123.9M | 204.3M | 235.3M | 180.0M | 189.0M | |
Total Current Liabilities | 237.0M | 276.4M | 876.2M | 428.4M | 367.8M | 386.2M | |
Total Stockholder Equity | 845.3M | 967.5M | 1.1B | 1.1B | 1.2B | 1.2B | |
Other Liab | 57.9M | 64.5M | 79.7M | 46.2M | 53.1M | 33.7M | |
Property Plant And Equipment Net | 110.4M | 114.2M | 119.7M | 132.0M | 133.6M | 140.3M | |
Current Deferred Revenue | 90.9M | 100.1M | 112.2M | 118.9M | 132.3M | 138.9M | |
Net Debt | (26.5M) | 30.2M | 179.0M | 286.4M | 113.1M | 118.8M | |
Retained Earnings | 258.8M | 290.7M | 368.6M | 390.7M | 370.4M | 388.9M | |
Accounts Payable | 46.4M | 40.3M | 71.5M | 63.4M | 45.0M | 25.0M | |
Cash | 127.2M | 485.9M | 349.1M | 330.4M | 501.0M | 526.0M | |
Non Current Assets Total | 757.6M | 995.1M | 1.4B | 1.3B | 1.3B | 1.4B | |
Non Currrent Assets Other | 151.9M | 176.2M | 191.3M | 164.5M | 64.4M | 52.5M | |
Long Term Debt | 135.4M | 50M | 467.2M | 566.6M | 569.7M | 598.1M | |
Cash And Short Term Investments | 127.2M | 485.9M | 349.1M | 330.4M | 501.0M | 526.0M | |
Net Receivables | 218.4M | 190.1M | 240.9M | 299.5M | 263.9M | 277.1M | |
Common Stock Total Equity | 51K | 53K | 54K | 55K | 49.5K | 47.0K | |
Common Stock Shares Outstanding | 42.9M | 43.7M | 47.9M | 45.9M | 45.2M | 36.4M | |
Liabilities And Stockholders Equity | 1.2B | 1.8B | 2.1B | 2.2B | 2.2B | 2.3B | |
Non Current Liabilities Total | 158.6M | 580.6M | 119.6M | 652.2M | 670.1M | 703.6M | |
Inventory | 108.0M | 96.3M | 119.9M | 147.5M | 110.1M | 115.6M | |
Other Current Assets | 15.2M | 41.0M | 48.3M | 77.4M | 52.6M | 55.2M | |
Other Stockholder Equity | 595.9M | 682.3M | 786.5M | 756.4M | 832.0M | 873.6M | |
Total Liab | 395.6M | 857.0M | 995.8M | 1.1B | 1.0B | 1.1B | |
Property Plant And Equipment Gross | 110.4M | 114.2M | 119.7M | 132.0M | 273.0M | 286.7M | |
Total Current Assets | 483.2M | 829.4M | 780.7M | 881.8M | 927.6M | 973.9M | |
Accumulated Other Comprehensive Income | (9.4M) | (5.5M) | (8.4M) | (17.1M) | (13.4M) | (14.1M) | |
Short Term Debt | 10.1M | 12.2M | 488.2M | 10.8M | 10.5M | 10.0M | |
Common Stock | 51K | 53K | 54K | 55K | 56K | 53.2K | |
Property Plant Equipment | 54.2M | 59.1M | 119.7M | 94.0M | 108.1M | 113.5M | |
Other Assets | 100.7M | 268.5M | 225.6M | 139.0M | 159.8M | 167.8M | |
Good Will | 336.5M | 499.3M | 738.9M | 734.3M | 735.8M | 772.6M | |
Intangible Assets | 124.9M | 168.2M | 277.6M | 242.9M | 277.8M | 291.7M | |
Net Tangible Assets | 845.3M | 967.5M | 130.2M | 153.0M | 175.9M | 297.7M | |
Retained Earnings Total Equity | 258.8M | 290.7M | 368.6M | 390.7M | 449.3M | 471.8M | |
Capital Surpluse | 780.9M | 920.4M | 1.0B | 1.0B | 1.2B | 729.3M | |
Deferred Long Term Liab | 39.1M | 4.3M | 51.7M | 2.1M | 1.9M | 1.8M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Omnicell using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Omnicell Stock
When determining whether Omnicell is a strong investment it is important to analyze Omnicell's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omnicell's future performance. For an informed investment choice regarding Omnicell Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.68) | Earnings Share (0.46) | Revenue Per Share 24.275 | Quarterly Revenue Growth (0.15) | Return On Assets (0.01) |
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.